Literature DB >> 18515403

Pathology of sentinel lymph nodes for melanoma.

M G Cook1, S Di Palma.   

Abstract

As a concept sentinel lymph node biopsy seems attractive in that it attempts to identify the first lymph node, rather than the nearest node, draining a particular anatomic area where a tumour has arisen. Pathological assessment can then indicate whether metastases are present and the procedure is either a strong prognostic indicator or possibly therapeutic in itself. These comments apply to any tumour type, but with melanoma the pathological procedure is more problematic and any benefits above prognosis and staging are not universally accepted. The procedure does give accurate staging without the extra morbidity of regional node dissection and many patients gain psychological support from the information gained.

Entities:  

Mesh:

Year:  2008        PMID: 18515403     DOI: 10.1136/jcp.2006.042036

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Histopathology report of cutaneous melanoma and sentinel lymph node in Europe: a web-based survey by the Dermatopathology Working Group of the European Society of Pathology.

Authors:  Anna Batistatou; Martin G Cook; Daniela Massi
Journal:  Virchows Arch       Date:  2009-04-08       Impact factor: 4.064

2.  Multicolor imaging of lymphatic function with two nanomaterials: quantum dot-labeled cancer cells and dendrimer-based optical agents.

Authors:  Hisataka Kobayashi; Mikako Ogawa; Nobuyuki Kosaka; Peter L Choyke; Yasuteru Urano
Journal:  Nanomedicine (Lond)       Date:  2009-06       Impact factor: 5.307

3.  Molecular dermatopathology in malignant melanoma.

Authors:  Marie-Annick Reginster; Claudine Pierard-Franchimont; Gérald E Piérard; Pascale Quatresooz
Journal:  Dermatol Res Pract       Date:  2011-10-20

4.  Favourable prognostic role of histological regression in stage III positive sentinel lymph node melanoma patients.

Authors:  D Zugna; R Senetta; S Osella-Abate; M T Fierro; A Pisacane; A Zaccagna; A Sapino; V Bataille; A Maurichi; F Picciotto; P Cassoni; P Quaglino; S Ribero
Journal:  Br J Cancer       Date:  2017-11-09       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.